Truvestments Capital’s Core Laboratories CLB Stock Holding History

Truvestments Capital’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$36K	Buy	+310	New	+$35K	0.02%	435

Other funds holding CLB

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Royal London Asset Management United Kingdom $47.7B AUM 29.41% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Truvestments Capital's CLB Position: Q3 2018 in Review

Truvestments Capital opened a new position in Core Laboratories (CLB) in Q3 2018: 310 shares worth $36K. The stake represents 0.02% of the portfolio and ranks #435 among its holdings.

360 funds tracked by Wall St. Rank hold CLB as of Q3 2018.

Truvestments Capital held 310 shares of Core Laboratories worth $36K as of Q3 2018.
Core Laboratories was a new Truvestments Capital position in Q3 2018.
Core Laboratories made up 0.02% of Truvestments Capital's portfolio in Q3 2018, its #435 holding.
360 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.

Based on Truvestments Capital's 13F filing for Q3 2018, filed 22 Oct 2018.